Live from the NIH registry
Studies recruiting near Greeley right now
Top 25 of 156 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Breast Cancer
Phase 3
Interventional 400 participants sought
Rocky Mountain Cancer Centers LLP — Longmont, Colorado (24.5 mi)
· Sponsor: Pfizer
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Pancreatic Cancer, Pancreatic Cancer Metastatic
Phase 3
Interventional 570 participants sought
Poudre Valley Health Care, Inc — Fort Collins, Colorado (20.2 mi)
· Sponsor: Immuneering Corporation
Impact of Circulating and Tissue-specific Lipids on Vascular Function and Insulin Sensitivity in Chronic Night Shift Workers
Circadian Rhythm Sleep Disorder of Shift Work Type, Metabolic Disease
N/A
Interventional 50 participants sought
Colorado State University — Fort Collins, Colorado (20.2 mi)
· Sponsor: Colorado State University
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Breast Neoplasms, Neoplasm Metastasis
Phase 3
Interventional 800 participants sought
Banner MD Anderson Cancer Center at North Colorado Medical Center — Greeley, Colorado (3.3 mi)
· Sponsor: Eli Lilly and Company
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
North Colorado Medical Center — Greeley, Colorado (3.3 mi)
· Sponsor: SWOG Cancer Research Network
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
UCHealth Greeley Hospital — Greeley, Colorado (3.3 mi)
· Sponsor: NRG Oncology
Combination Antibiotic Therapy for Staphylococcus Aureus Bacteremia
Staphylococcus Aureus Bacteremia
Phase 4
Interventional 2,096 participants sought
Platte Valley Hospital — Brighton, Colorado (29.8 mi)
· Sponsor: Intermountain Health Care, Inc.
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
Banner North Colorado Medical Center — Greeley, Colorado (3.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
N/A
Interventional 9,500 participants sought
Longmont United Hospital — Longmont, Colorado (24.5 mi)
· Sponsor: NRG Oncology
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 2,400 participants sought
UCHealth Greeley Hospital — Greeley, Colorado (3.3 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
Primary Open Angle Glaucoma
Phase 3
Interventional 130 participants sought
Eye Center of Northern Colorado /ID# 281798 — Fort Collins, Colorado (20.2 mi)
· Sponsor: AbbVie
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Acute Migraine
Phase 3
Interventional 1,000 participants sought
Advanced Neurosciences Research — Fort Collins, Colorado (20.2 mi)
· Sponsor: TriGemX Bio, Inc.
Improving Care for Rural Patients With Solid Tumors
Lung Cancer, Head and Neck Cancer
N/A
Interventional 320 participants sought
Greeley Campus — Greeley, Colorado (3.3 mi)
· Sponsor: University of Colorado, Denver
Countermeasures to Circadian Misalignment
Circadian Rhythm Sleep Disorder of Shift Work Type, Metabolic Disease
N/A
Interventional 32 participants sought
Colorado State University — Fort Collins, Colorado (20.2 mi)
· Sponsor: Colorado State University
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
UCHealth Greeley Hospital — Greeley, Colorado (3.3 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
Renal Pelvis and Ureter Urothelial Carcinoma
Phase 2, Phase 3
Interventional 131 participants sought
UCHealth Greeley Hospital — Greeley, Colorado (3.3 mi)
· Sponsor: National Cancer Institute (NCI)
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Prostate Cancer (Adenocarcinoma)
Phase 3
Interventional 830 participants sought
UCHealth Greeley Hospital — Greeley, Colorado (3.3 mi)
· Sponsor: Canadian Cancer Trials Group
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Rocky Mountain Cancer Centers, LLP — Longmont, Colorado (24.5 mi)
· Sponsor: Relay Therapeutics, Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
UCHealth Greeley Hospital — Greeley, Colorado (3.3 mi)
· Sponsor: SWOG Cancer Research Network
Exactech Shoulder Post Market Clinical Follow-up Study
Osteo Arthritis Shoulders, Osteonecrosis
N/A
Observational 20,000 participants sought
Orthopaedic and Spine Center of the Rockies — Fort Collins, Colorado (20.2 mi)
· Sponsor: Exactech
Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity
Primary Sjögren's Syndrome
Phase 2
Interventional 180 participants sought
Site Number - 1014 — Fort Collins, Colorado (20.2 mi)
· Sponsor: Immunovant Sciences GmbH
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic
Phase 3
Interventional 680 participants sought
Rocky Mountain Cancer Centers LLP — Longmont, Colorado (24.5 mi)
· Sponsor: Pfizer
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
Generalized Myasthenia Gravis
Phase 3
Interventional 264 participants sought
Advanced Neurosciences Research LLC — Longmont, Colorado (24.5 mi)
· Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Generalized Myasthenia Gravis
Phase 3
Interventional 231 participants sought
Site Number - 1027 — Fort Collins, Colorado (20.2 mi)
· Sponsor: Immunovant Sciences GmbH
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
Banner North Colorado Medical Center — Greeley, Colorado (3.3 mi)
· Sponsor: National Cancer Institute (NCI)